Cellular immune response after vaccination in patients with cance: review on past and present experiences
Patients with cancer are at particular risk for infection but also have diminished vaccine responses, usually quantified by the level of specific antibodies. Nonetheless, vaccines are specifically recommended in this vulnerable patient group. Here, we discuss the cellular part of the vaccine respons...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
25 January 2022
|
| In: |
Vaccines
Year: 2022, Volume: 10, Issue: 2, Pages: 1-16 |
| ISSN: | 2076-393X |
| DOI: | 10.3390/vaccines10020182 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/vaccines10020182 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2076-393X/10/2/182 
|
| Author Notes: | Maria Madeleine Rüthrich, Nicola Giesen, Sibylle C. Mellinghoff, Christina T. Rieger and Marie von Lilienfeld-Toal |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 179998835X | ||
| 003 | DE-627 | ||
| 005 | 20230427150854.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220421s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/vaccines10020182 |2 doi | |
| 035 | |a (DE-627)179998835X | ||
| 035 | |a (DE-599)KXP179998835X | ||
| 035 | |a (OCoLC)1341459041 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rüthrich, Maria Madeleine |d 1990- |e VerfasserIn |0 (DE-588)1203565593 |0 (DE-627)1688544569 |4 aut | |
| 245 | 1 | 0 | |a Cellular immune response after vaccination in patients with cance |b review on past and present experiences |c Maria Madeleine Rüthrich, Nicola Giesen, Sibylle C. Mellinghoff, Christina T. Rieger and Marie von Lilienfeld-Toal |
| 264 | 1 | |c 25 January 2022 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.04.2022 | ||
| 520 | |a Patients with cancer are at particular risk for infection but also have diminished vaccine responses, usually quantified by the level of specific antibodies. Nonetheless, vaccines are specifically recommended in this vulnerable patient group. Here, we discuss the cellular part of the vaccine response in patients with cancer. We summarize the experience with vaccines prior to and during the SARS-CoV-2 pandemic in different subgroups, and we discuss why, especially in patients with cancer, T cells may be the more reliable correlate of protection. Finally, we provide a brief outlook on options to improve the cellular response to vaccines. | ||
| 650 | 4 | |a cancer | |
| 650 | 4 | |a cellular response | |
| 650 | 4 | |a malignancy | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a vaccination | |
| 700 | 1 | |a Giesen, Nicola |d 1983- |e VerfasserIn |0 (DE-588)141844272 |0 (DE-627)631828524 |0 (DE-576)32643657X |4 aut | |
| 700 | 1 | |a Mellinghoff, Sibylle Christiane |d 1990- |e VerfasserIn |0 (DE-588)112248822X |0 (DE-627)875699855 |0 (DE-576)481342443 |4 aut | |
| 700 | 1 | |a Rieger, Christina |d 1975- |e VerfasserIn |0 (DE-588)124900690 |0 (DE-627)367769875 |0 (DE-576)294559108 |4 aut | |
| 700 | 1 | |a Lilienfeld-Toal, Marie von |d 1971- |e VerfasserIn |0 (DE-588)121251268 |0 (DE-627)081183585 |0 (DE-576)29260937X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vaccines |d Basel : MDPI, 2013 |g 10(2022), 2, Artikel-ID 182, Seite 1-16 |h Online-Ressource |w (DE-627)736559205 |w (DE-600)2703319-3 |w (DE-576)37898585X |x 2076-393X |7 nnas |a Cellular immune response after vaccination in patients with cance review on past and present experiences |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g number:2 |g elocationid:182 |g pages:1-16 |g extent:16 |a Cellular immune response after vaccination in patients with cance review on past and present experiences |
| 856 | 4 | 0 | |u https://doi.org/10.3390/vaccines10020182 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2076-393X/10/2/182 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220421 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 141844272 |a Giesen, Nicola |m 141844272:Giesen, Nicola |d 910000 |d 910100 |e 910000PG141844272 |e 910100PG141844272 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN179998835X |e 4119794172 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"25 January 2022"}],"language":["eng"],"id":{"doi":["10.3390/vaccines10020182"],"eki":["179998835X"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"pubHistory":["1.2013 -"],"recId":"736559205","note":["Gesehen am 14.02.13"],"disp":"Cellular immune response after vaccination in patients with cance review on past and present experiencesVaccines","part":{"issue":"2","extent":"16","year":"2022","text":"10(2022), 2, Artikel-ID 182, Seite 1-16","pages":"1-16","volume":"10"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Vaccines","title":"Vaccines","subtitle":"open access journal"}],"id":{"eki":["736559205"],"issn":["2076-393X"],"zdb":["2703319-3"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedKey":"2013","publisher":"MDPI","publisherPlace":"Basel","dateIssuedDisp":"2013-"}]}],"person":[{"display":"Rüthrich, Maria Madeleine","family":"Rüthrich","given":"Maria Madeleine","role":"aut"},{"role":"aut","given":"Nicola","family":"Giesen","display":"Giesen, Nicola"},{"given":"Sibylle Christiane","display":"Mellinghoff, Sibylle Christiane","family":"Mellinghoff","role":"aut"},{"role":"aut","given":"Christina","family":"Rieger","display":"Rieger, Christina"},{"role":"aut","display":"Lilienfeld-Toal, Marie von","family":"Lilienfeld-Toal","given":"Marie von"}],"physDesc":[{"extent":"16 S."}],"title":[{"subtitle":"review on past and present experiences","title":"Cellular immune response after vaccination in patients with cance","title_sort":"Cellular immune response after vaccination in patients with cance"}],"recId":"179998835X","note":["Gesehen am 21.04.2022"],"name":{"displayForm":["Maria Madeleine Rüthrich, Nicola Giesen, Sibylle C. Mellinghoff, Christina T. Rieger and Marie von Lilienfeld-Toal"]}} | ||
| SRT | |a RUETHRICHMCELLULARIM2520 | ||